Citigroup Upgrades Agilon Health to Neutral, Raises Price Target to $115

Benzinga Newsdesk www.benzinga.com Positive 79.6%

Neg 0% Neu 0% Pos 79.6%

Citigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and raises the price target from $105 to $115.